Effect of add on intravenous lignocaine on delirium and cognitive dysfunction after surgery in patients undergoing total hip replacement: a double blinded randomised controlled trial
Not Applicable
- Conditions
- Health Condition 1: M161- Unilateral primary osteoarthritisof hip
- Registration Number
- CTRI/2019/10/021816
- Lead Sponsor
- Eslavath Madhurima
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients above 18 years undergoing Total Hip Replacement.
Exclusion Criteria
Preexisting neurocognitive dysfunctions,
Refusal for the consent ,
Auditory or visual disability,
NuDESC score >2 pre-operatively,
MMSE score < 23 pre-operatively,
Subjects with known sensitivity to lignocaine,
On beta blocker therapy,
Hemodynamically unstable,
Subjects with deranged liver, renal functions
THR done under general anaesthesia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method